GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,422,000 | -1.9% | 193,478 | -1.8% | 1.13% | +18.6% |
| Q1 2022 | $8,586,000 | -1.6% | 197,117 | -0.4% | 0.95% | +5.1% |
| Q4 2021 | $8,724,000 | +14.9% | 197,835 | -0.4% | 0.90% | +3.7% |
| Q3 2021 | $7,591,000 | +2.5% | 198,675 | +6.8% | 0.87% | +2.1% |
| Q2 2021 | $7,406,000 | +15.5% | 186,003 | +3.5% | 0.86% | +9.1% |
| Q1 2021 | $6,412,000 | +6.5% | 179,666 | +9.8% | 0.78% | +0.3% |
| Q4 2020 | $6,023,000 | +11.2% | 163,673 | +13.8% | 0.78% | -0.5% |
| Q3 2020 | $5,415,000 | +29.0% | 143,878 | +39.8% | 0.79% | +15.1% |
| Q2 2020 | $4,199,000 | +24.0% | 102,943 | +15.2% | 0.68% | +4.6% |
| Q1 2020 | $3,385,000 | -22.5% | 89,362 | -3.9% | 0.65% | -1.7% |
| Q4 2019 | $4,368,000 | +5.2% | 92,969 | -4.5% | 0.66% | -1.3% |
| Q3 2019 | $4,152,000 | +6.4% | 97,303 | -0.2% | 0.67% | +6.8% |
| Q2 2019 | $3,902,000 | +4.6% | 97,506 | +9.2% | 0.63% | -0.8% |
| Q1 2019 | $3,730,000 | +14.3% | 89,265 | +4.5% | 0.64% | -1.2% |
| Q4 2018 | $3,264,000 | -8.9% | 85,412 | -4.2% | 0.64% | +6.1% |
| Q3 2018 | $3,583,000 | +14.2% | 89,202 | +14.6% | 0.61% | +6.7% |
| Q2 2018 | $3,137,000 | +3.0% | 77,832 | -0.2% | 0.57% | +0.9% |
| Q1 2018 | $3,046,000 | +4.7% | 77,977 | -5.0% | 0.56% | +7.0% |
| Q4 2017 | $2,910,000 | -17.3% | 82,056 | -5.3% | 0.53% | -20.4% |
| Q3 2017 | $3,517,000 | -1.6% | 86,639 | +4.5% | 0.66% | -6.1% |
| Q2 2017 | $3,575,000 | +5.9% | 82,926 | +3.5% | 0.70% | +1.4% |
| Q1 2017 | $3,376,000 | +15.7% | 80,093 | +5.6% | 0.69% | +9.6% |
| Q4 2016 | $2,919,000 | -6.4% | 75,823 | +4.8% | 0.63% | -9.1% |
| Q3 2016 | $3,120,000 | +2.4% | 72,352 | +2.9% | 0.70% | -2.8% |
| Q2 2016 | $3,046,000 | +13.2% | 70,297 | +5.9% | 0.72% | +10.5% |
| Q1 2016 | $2,691,000 | +5.4% | 66,365 | +2.6% | 0.65% | -2.0% |
| Q4 2015 | $2,552,000 | +8.8% | 64,710 | +6.1% | 0.66% | +6.1% |
| Q3 2015 | $2,345,000 | -5.2% | 61,000 | +2.7% | 0.62% | +0.6% |
| Q2 2015 | $2,473,000 | -7.5% | 59,395 | +2.5% | 0.62% | -8.6% |
| Q1 2015 | $2,674,000 | +13.4% | 57,940 | +5.1% | 0.68% | +9.0% |
| Q4 2014 | $2,357,000 | +158.4% | 55,150 | +178.1% | 0.62% | +140.7% |
| Q3 2014 | $912,000 | -14.0% | 19,832 | 0.0% | 0.26% | -16.2% |
| Q2 2014 | $1,061,000 | -2.8% | 19,832 | -3.0% | 0.31% | -9.1% |
| Q1 2014 | $1,092,000 | -1.1% | 20,435 | -1.2% | 0.34% | -4.0% |
| Q4 2013 | $1,104,000 | +6.5% | 20,685 | 0.0% | 0.35% | -2.2% |
| Q3 2013 | $1,037,000 | -2.0% | 20,685 | -2.4% | 0.36% | -5.7% |
| Q2 2013 | $1,058,000 | – | 21,185 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |